BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14612969)

  • 1. Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.
    Januszkiewicz D; Wysoki J; Lewandowski K; Pernak M; Nowicka K; Rembowska J; Nowak J
    Int J Mol Med; 2003 Dec; 12(6):935-8. PubMed ID: 14612969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
    Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
    Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts.
    Swiggers SJ; Nibbeling HA; Zeilemaker A; Kuijpers MA; Mattern KA; Zijlmans JM
    Exp Cell Res; 2004 Jul; 297(2):434-43. PubMed ID: 15212946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeres and telomerase in normal and malignant haematopoietic cells.
    Norrback KF; Roos G
    Eur J Cancer; 1997 Apr; 33(5):774-80. PubMed ID: 9282116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.
    Zhao YM; Li JY; Lan JP; Lai XY; Luo Y; Sun J; Yu J; Zhu YY; Zeng FF; Zhou Q; Huang H
    Biochem Biophys Res Commun; 2008 May; 369(4):1114-9. PubMed ID: 18339310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of telomerase activity and its related genes expression in leukemia cells].
    Xia F; Yuan Y; Chen R; Liu P; Zhou H; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):86-9. PubMed ID: 11877056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.
    Wolf D; Rumpold H; Koppelstätter C; Gastl GA; Steurer M; Mayer G; Gunsilius E; Tilg H; Wolf AM
    Cancer Immunol Immunother; 2006 Oct; 55(10):1198-208. PubMed ID: 16362412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
    Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
    Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomeres and telomerase in normal and leukemic hematopoietic cells.
    Engelhardt M; Wäsch R; Guo Y
    Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP; Miaw J; Shai SE; Chen CY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase in hematologic neoplasia.
    Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
    Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
    Getliffe KM; Al Dulaimi D; Martin-Ruiz C; Holder RL; von Zglinicki T; Morris A; Nwokolo CU
    Aliment Pharmacol Ther; 2005 Jan; 21(2):121-31. PubMed ID: 15679761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.